FDA.reportPublic FDA data

CBD-KINGS

Manufacturer
1ST MEDX LLC
Effective date
2022-01-25
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 22:10:26

Label at a glance#

ProductCBD-KINGS WITH LIDOCAINE 4%
Active ingredientLIDOCAINE, MENTHOL, METHYL SALICYLATE, CAMPHOR OIL, CAPSICUM
Label structure11 sections

Indications and uses

FOR THE TEMPORARY RELIEF OF MINOR ACHES AND PAINS OF MUSCLES AND JOINTS ASSOCIATED WITH ARTHRITIS, SIMPLE BACKACHE, STRAINS, SPRAINS, MUSCLE SORENESS AND STIFFNESS.

Dosage and administration

FOR ADULTS AND CHILDREN 12 YEARS AND OVER. APPLY PATCH TO AFFECTED AREA 1 TO 2 TIMES DAILY OR AS DIRECTED BY PHYSICIAN. CLEAN AND DRY THE AFFECTED AREA. OPEN POUCH AND REMOVE PROTECTIVE FILM AND APPLY PATCH TO AFFECTED AREA. WASH HANDS WITH SOAP AND WATER AFTER APPLYING PATCH. RESEAL POUCH CONTAINING UNUSED PATCHES AFTER USE.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS:

OTC - ACTIVE INGREDIENT SECTION

LIDOCAINE 4%

MENTHOL 3%

METHYL SALICYLATE 9%

CAMPHOR 1.2%

CAPSICUM 0.125%

PURPOSE

OTC - PURPOSE SECTION

TOPICAL ANESTHETIC

TOPICAL ANESTHETIC

TOPICAL ANESTHETIC

TOPICAL ANESTHETIC

TOPICAL ANESTHETIC

USES:

INDICATIONS & USAGE SECTION

FOR THE TEMPORARY RELIEF OF MINOR ACHES AND PAINS OF MUSCLES AND JOINTS ASSOCIATED WITH ARTHRITIS, SIMPLE BACKACHE, STRAINS, SPRAINS, MUSCLE SORENESS AND STIFFNESS.

WARNINGS:

WARNINGS SECTION

FOR EXTERNAL USE ONLY.

  • USE ONLY AS DIRECTED.
  • AVOID CONTACT WITH EYES AND MUCOUS MEMBRANES.
  • DO NOT USE WITH HEATING DEVICES OR PADS.
  • DO NOT USE ON WOUNDS, CUTS, DAMAGED OR INFECTED SKIN AS WELL AS IN THE EYES, MOUTH, GENITALS, OR ANY OTHER MUCOUS MEMBRANES.
  • DO NOT COVER WITH BANDAGES.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN.

IF SWALLOWED, CALL POISON CONTROL.

WARNINGS AND PRECAUTIONS SECTION

IF CONTACT DOES OCCUR WITH EYES, RINSE WITH COLD WATER AND CALL A DOCTOR.

CHILDREN UNDER 12 YEARS OLD, CONSULT A DOCTOR BEFORE USE.

  • IF YOU ARE ALLERGIC TO ANY INGREDIENTS IN THIS PRODUCT CONSULT A DOCTOR BEFORE USE.
  • CONSULT YOUR PHYSICIAN: IF PREGNANT OR IF PAIN PERSISTS OR WORSENS.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

FOR ADULTS AND CHILDREN 12 YEARS AND OVER. APPLY PATCH TO AFFECTED AREA 1 TO 2 TIMES DAILY OR AS DIRECTED BY PHYSICIAN. CLEAN AND DRY THE AFFECTED AREA. OPEN POUCH AND REMOVE PROTECTIVE FILM AND APPLY PATCH TO AFFECTED AREA. WASH HANDS WITH SOAP AND WATER AFTER APPLYING PATCH. RESEAL POUCH CONTAINING UNUSED PATCHES AFTER USE.

OTHER INFORMATION:

OTHER SAFETY INFORMATION

STORE BELOW 90°F/32°C

INACTIVE INGREDIENTS:

INACTIVE INGREDIENT SECTION

HEMP OIL 125MG, GLYCERIN 25%, POLYACRYLIC ACID 5%, PROPYLENE GLYCOL 2%, METHYL SALICYLATE, GLYCERIN, SODIUM POLYACRYLATE, DIHYDROXYALUMINUM AMINOACETATE, ISOPROPYL MYRISTATE, TARTARIC ACID, PROPYLENE GLYCOL, SORBITOL, EDTA2-NA, PROPYL  P-HYDROXYBENZOATE, TWEEN 80, TITANIUM DIOXIDE, EXTRA MEDICAL PURIFIED WATER.

QUESTIONS?

OTC - QUESTIONS SECTION

888-319-6339

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

01b UC_Front_CBD-Kings_Hemp Oil patch w-Lidocaine_72137-150-0601b UC_Front_CBD-Kings_Hemp Oil patch w-Lidocaine_72137-150-06

01b UC_Back_CBD-Kings_Hemp Oil patch w-Lidocaine_72137-150-0601b UC_Back_CBD-Kings_Hemp Oil patch w-Lidocaine_72137-150-06

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72137-150-062022-02-01C16284748780-1d6a99b39-9ec7-a426-e053-dadaa90af4c21st MedX - CBD-KINGS WITH LIDOCAINE 4% (72137-150)
72137-150-062022-01-28C16284748780-1d6a99b39-9ec7-a426-e053-dadaa90af4c21st MedX - CBD-KINGS WITH LIDOCAINE 4% (72137-150)

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72137-15072137-150-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Name, UNII, Kind table
NameUNIIKind
HEMPTD1MUT01Q7IACT
GLYCERINPDC6A3C0OXIACT
POLYACRYLIC ACID (450000 MW)KD3S7H73D3IACT
PROPYLENE GLYCOL6DC9Q167V3IACT
SODIUM POLYACRYLATE (2500000 MW)05I15JNI2JIACT
DIHYDROXYALUMINUM AMINOACETATEDO250MG0W6IACT
ISOPROPYL MYRISTATE0RE8K4LNJSIACT
TARTARIC ACIDW4888I119HIACT
SORBITOL506T60A25RIACT
EDETATE DISODIUM7FLD91C86KIACT
PROPYLPARABENZ8IX2SC1OHIACT
POLYSORBATE 806OZP39ZG8HIACT
TITANIUM DIOXIDE15FIX9V2JPIACT
WATER059QF0KO0RIACT
LIDOCAINE98PI200987ACTIB
MENTHOLL7T10EIP3AACTIB
METHYL SALICYLATELAV5U5022YACTIB
CAMPHOR OIL75IZZ8Y727ACTIB
CAPSICUM00UK7646FGACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
066da7f4-1c24-ac76-e063-6394a90ae68024ba7165-453c-4afe-8ebf-b1fdfd969f392023-09-28WarningsExact identifier
spl set id: 24ba7165-453c-4afe-8ebf-b1fdfd969f39

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.